UPS Healthcare Continues Investment In Personalized Medicine; Expands Global Cell And Gene Services Capacity
February 11 2021 - 7:00AM
UPS Healthcare announced today an investment and further expansion
of its capabilities in cell and gene services via Marken, a UPS
company. UPS Healthcare is adding eight centers of excellence to
support Marken’s global network of cell and gene services, bringing
the total to 14 certified sites. The expanded network will support
Marken’s well-established services including cryogenic transport
services, patient data protection, superior temperature monitoring
technology and real-time GPS tracking.
As an important part of UPS Healthcare’s offerings, Marken’s
worldwide network includes 56 certified locations to handle the
sensitive shipments required during the clinical development of
cell and gene therapies. The eight new locations – New York, Miami,
Amsterdam, Paris, Melbourne, Sidney, Tokyo and Seoul – strengthen
Marken’s global Center of Excellence network, which already
includes centers in Los Angeles, San Francisco, Philadelphia,
London, Frankfurt and Singapore.
Marken has established a global control center in its Research
Triangle Park headquarters where it monitors all activities
relative to its cell and gene clinical trials. The control center
monitors location and temperature in real time for all shipments,
leverages UPS’s expansive global network, monitors flight status
and manages all potential supply chain disruptions.
Wes Wheeler, president of UPS Healthcare, commented, “UPS
Healthcare continues to expand our service portfolio to support our
growing number of cell and gene clients. These new breakthrough
therapies are among the most complex and sensitive in our industry
and we are planning on a best-in-class level of performance. We
will continue to invest in our capabilities and maintain Marken’s
leadership position in the clinical trial logistics industry.”
About UPS Healthcare and Marken
UPS Healthcare delivers unparalleled logistics expertise to its
customers around the world. UPS Healthcare has more than 10 million
square feet of cGMP- or cGDP-compliant healthcare distribution
space globally. UPS Healthcare services include inventory
management, temperature-controlled packaging and shipping, storage
and fulfillment of medical devices, labs and clinical trial
logistics. UPS Healthcare’s global infrastructure, its newest UPS
Premier visibility service, its track and trace technology, and its
global quality system are well-suited to meet today’s complex
logistics demands for the pharmaceutical, medical device and
laboratory diagnostic industries.
Marken is a wholly owned subsidiary of UPS and is a critical
part of UPS Healthcare. With Polar Speed and Marken included, the
UPS Healthcare division staffs 128 locations with 5,500 employees
worldwide. Marken offers a state-of-the-art GMP-compliant depot
network and logistic hubs for clinical drug product storage and
distribution in 56 locations worldwide, while maintaining the
leading position for Direct to Patient and Home Health care
services, biological sample shipments and biological kit
production. Marken’s dedicated 1,600 staff members manage 100,000
drug product and biological sample shipments every month at all
temperature ranges in more than 220 countries. Additional services
such as ancillary material sourcing, storage and distribution,
shipment lane verification and qualifications, as well as GDP,
regulatory and compliance consultancy add to Marken’s unique
position in the pharma and logistics industry.
Christine Noble, info@marken.com, www.marken.com
United Parcel Service (NYSE:UPS)
Historical Stock Chart
From Aug 2024 to Sep 2024
United Parcel Service (NYSE:UPS)
Historical Stock Chart
From Sep 2023 to Sep 2024